# Abrdn Life Sciences Investors (HQL): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Abrdn Life Sciences Investors (HQL) is 43/100, ranked against 24,000+ stocks in 35 markets (Quality 34, Value 58, Momentum 43, each scored against its sector).

- StockRank: 43/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 34, Value 58, Momentum 43: each a 0-100 percentile within the stock's sector.
- Position: #15,382 overall, #1,844 in Financial Services.
- Listing: United States, NYQ; Financial Services / Asset Management.
- Last close: 17.26 USD on 13 Oct 2026.
- Insider filings, last 180 days: directors bought USD 10K.

Source: https://moatmap.ai/stock/HQL
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker